Background-The participation of endothelin-1 (ET-1) in the control of vascular tone in humans has been questioned, on the basis of the finding of subthreshold immunoreactive (ir) ET-1 plasma levels. However, because most ET-1 is secreted abluminally, it might attain a higher concentration in the tunica media than in plasma. Furthermore, evidence indicates that vascular smooth muscle cells (VSMCs) can synthesize ET-1 on stimulation in vitro. We therefore looked for irET-1 in the different layers of the wall of human arteries, including renal, gastric, and internal thoracic artery wall, obtained ex vivo from consenting patients with coronary artery disease and/or high blood pressure undergoing surgery, as well as from young organ donors. Methods and Results-We performed immunohistochemistry with specific anti-ET-1 and anti-vWF antibodies followed by detection with an avidin-biotin complex ultrasensitive kit. The presence of preproET-1 and human endothelinconverting enzyme-1 (hECE-1) mRNA was also investigated by reverse transcription-polymerase chain reaction in homogenates of vessel wall, including preparations deprived of both endothelium and adventitia, and in isolated VSMCs. We detected irET-1 in the endothelium of all arteries and in the tunica media of internal thoracic artery from most patients with coronary artery disease. PreproET-1 and hECE-1 mRNA was also detected in VSMCs isolated from these vessels. irET-1 and irvWF staining in endothelium and tunica media was measured by use of microscope-coupled computer-assisted technology. Significant correlations between the amount of irET-1 in the tunica media and mean blood pressure (PϽ0.05), total serum cholesterol (PϽ0.05), and number of atherosclerotic sites (PϽ0.001) were found. Thus, in organ donors, irET-1 was detectable almost exclusively in endothelial cells, whereas in patients with coronary artery disease and/or arterial hypertension, sizable amounts of irET-1 were detectable in the tunica media of different types of arteries. In addition, VSMCs isolated from these vessels coexpressed the preproET-1 and hECE-1 genes. Conclusions-Collectively, these findings are consistent with the contention that endothelial damage occurs in most patients with atherosclerosis and/or hypertension and that ET-1 is synthesized in VSMCs of these patients. (Circulation. 1999;99:1147-1155.)
ndothelins are a family of isopeptides with multiple biological actions that may be relevant for the regulation of vascular tone, blood pressure, and sodium and water homeostasis. [1] [2] [3] Endothelin-1 (ET-1), originally isolated from the supernatant of porcine aortic endothelial cells, is the predominant isopeptide in the vascular endothelium. 1 Because of its pleiotropic effects on the vasculature, it was hypothesized to intervene in the regulation of vascular tone under pathophysiological conditions and to play a role in the pathogenesis of hypertension, atherosclerosis, and related cardiovascular disease. 4 -7 However, this contention was challenged on the basis of the observation that although plasma levels of the peptide were increased in atherosclerotic patients and in hypertensives with cardiovascular disease, 8 -11 they were either only slightly increased or normal in most hypertensives. 6, 12 Furthermore, they are generally subthreshold, ie, lower than the 30 to 300 pmol/L that elicits a vasoconstrictor response in various smooth muscle (SM) preparations in vitro. 5, 7 In vitro studies with endothelial cell monolayers suggest that Ն80% of ET-1 would be secreted abluminally through the basolateral portion of endothelial cells toward the tunica media, where it could act in a paracrine fashion, 13, 14 but this polarization was not found in the coronary vascular bed of isolated rat hearts. 15 In addition, it was reported that vascular smooth muscle cells (VSMCs) could express the preproET-1 gene in vitro under several experimental condi-tions, 16 thereby raising the possibility that this might also occur in vivo. We therefore hypothesized that the peptide could be detected in the tunica media of human vessels in vivo, where it was synthesized locally.
Thus, our purposes were to investigate (1) the presence and distribution of immunoreactive (ir) ET-1 in the different layers of the wall of these vessels, (2) the expression of preproET-1 gene in the tunica media and in VSMCs of human arteries obtained ex vivo from young organ donors and from patients with coronary artery disease and/or high blood pressure, and (3) the clinical correlates of irET-1 in the arterial wall.
Methods

Selection of Subjects
Consecutive otherwise healthy organ donors (nϭ5) and consenting patients undergoing coronary artery bypass graft surgery (nϭ19; age, 42 to 77 years), unilateral nephrectomy for kidney cancer (nϭ1), or surgery for lung (nϭ2) and gastric (nϭ1) cancer (age, 69 to 83 years) were investigated. The latter patients were selected so as to obtain different types of artery. Most arterial specimens were histologically normal, but 50% of those from coronary artery disease patients showed some intimal thickening.
In all patients, the presence and extension of atherosclerotic involvement was determined as described by Lerman et al. 8 The study followed the local ethical guidelines for human investigations.
Preparation of Vascular Tissues
After excision, tissues were immediately frozen in isopentane, cooled at Ϫ70°C over dry ice in the operating room, and stored at Ϫ195°C in liquid nitrogen until they were used for analyses. Frozen 7-to 10-m sections were cut with a cryostat (Leitz 1720 Digital) at Ϫ20°C and used for the immunohistochemistry studies. They were examined for localization of the mature ET-1 peptide and vWF as a marker of the endothelium.
Immunohistochemistry for ET-1
To visualize the distribution of irET-1 peptide, the following primary antibodies were used: rabbit anti-ET-1 antiserum (Peninsula Laboratories Inc) that shows a 7% cross-reactivity for ET-2 and ET-3 and a 17% cross-reactivity for human big ET-1 (proendothelin-1), 17, 18 a monoclonal anti-ET-1 antibody (IgG1) 19 (ABR) directed against an epitope encompassing amino acids 8 to 16 of ET-1. The latter antibody has Ͻ10% cross-reactivity for ET-2 and Ͻ10% for ET-3, and no cross-reactivity to nonrelated peptides. The reaction was detected with the Immunopure ABC Ultra Sensitive Staining Kit (Pierce). Serial 10-m slides of mounted vessel sections were fixed in 10% formalin for 5 minutes. Adjacent sections were incubated with an anti-vWF antibody (1:2000) (Dako). Sections were washed in PBS (pH 7.4) and incubated with normal goat serum (1/70) to block nonspecific binding for 20 minutes. Excess serum was then removed and replaced with the primary antibodies (1/500). Negative controls were carried out in all cases by treating an adjacent section with preimmune rabbit or mouse IgG (1/500), either by omitting the primary antibody or by preincubating it with a 10-fold higher concentration of ET-1. Sections were incubated with primary antibody at 37°C for 40 minutes. After a 10-minute wash, sections were incubated at room temperature for 30 minutes with a secondary biotin-conjugated goat anti-rabbit or anti-mouse IgG (1/200), with normal human serum (1/200), and with goat serum (1/70). They were rinsed again before incubation with avidin-biotin complex (30 minutes at room temperature), specially purified avidin (1/60), and specially prepared biotinylated horseradish peroxidase (1/60) constitute. The reaction was developed for 10 minutes with 20 mg 3-amino-9-ethylcarbazole (Sigma Chemical Co), 2.5 mL N,Ndimethyl formamide, 47.5 mL acetate buffer (0.2 mol/L sodium acetate, 0.2N glacial acetic acid), and 25 L 30% H 2 O 2 and was stopped with tap water. The sections were mounted with polyvinyl alcohol (Sigma).
Quantification of irET-1
For each artery section, Ն6 high-quality images were examined with the microscope (magnification ϫ20) and acquired on a personal computer coupled to the microscope by use of specially developed software (Studio Casti Imaging) under identical conditions of light in black and white using a gray scale, white being set to a maximum brightness value of 250 and black to 0. On each image, measurements on endothelium, tunica media, and background, the latter being defined as a tissue-free portion of the image in the vessel lumen, were performed. The endothelium was identified by comparison of each section with an adjacent one stained for vWF, the tunica media being defined as the portion of wall between the internal and external elastic laminae. The area of interest was outlined with a cursor, and the average gray was measured. To exclude the confounding effect of different backgrounds, the background value of each section was subtracted from each reading. The average withinsection coefficients of variation of the measurement of irET-1 in the endothelium and tunica media were 20% and 17%, respectively.
Immunofluorescence Studies
The monoclonal SM-E7 anti-SM myosin antibody, which binds selectively to SM-type myosin heavy chains (MHC) 1 and 2 (SM-1 and -2) expressed in VSMCs, 20, 21 was used. Cryosections 7 m thick from arteries and veins were fixed in 1.5% p-formaldehyde, rinsed in PBS for 10 minutes at room temperature, and then incubated at 37°C for 30 minutes with the appropriate dilution of SM-E7 (IgG, 2.5 g/mL) antibody. After being rinsed with PBS, the sections were treated with a rabbit anti-mouse IgG coupled with tetramethylrhodamine isothiocyanate (Dako) and mounted in polyvinyl alcohol. The specimens were observed with an Olympus BX 50 fluorescence microscope. The reactivity to SM-E7 and anti-␣-actin (Sigma) antibodies was tested in cultured cells (see below) at both an early and a late passage.
Immunofluorescence Studies of Endothelin-1-Converting Enzyme in VSMCs
VP-16 polyclonal antibody was produced in rabbits immunized with the 16-amino-acid peptide of the N-terminus endothelin-1-converting enzyme (ECE-1a)-specific isoform coupled with keyhole limpet hemocyanin. After affinity chromatography purification, the antibody reacted exclusively with the 120-kDa electrophoretic band contained in SDS extracts from cultured human umbilical vein endothelial cells. The aforementioned monoclonal anti-ET-1 was used. VSMCs were prepared from human aorta by use of a standard procedure 22 and used for immunofluorescence experiments after the third passage in vitro. Immunofluorescence assay was performed on 1.5% p-formaldehyde-fixed and Triton X-100 -permeabilized cells. The primary antibodies VP-16 and anti-ET-1, appropriately diluted, were mixed together and incubated for 30 minutes in a humidified chamber. After being rinsed with PBS, the cultures were incubated with a mixture of the secondary antibodies, ie, anti-rabbit IgG coupled with FITC and anti-mouse IgG coupled with rhodamine isothiocyanate (Dako) at the conditions described above. Controls were nonimmune rabbit IgG followed by anti-mouse IgG coupled with rhodamine isothiocyanate and nonimmune mouse IgG followed by anti-rabbit IgG coupled with FITC.
SM Cell Cultures
Arteries collected in the operating room were immediately placed in sterile Ringer's solution with penicillin and streptomycin at 4°C, cleaned of fat and connective tissue, and cut under a stereoscopic microscope. The intima was scraped away and the adventitia stripped away from the media in DMEM. The media was chopped fine and rinsed in Hanks' balanced medium (Sigma), and the small chunks obtained were placed in a small volume of medium containing 10% FCS, 200 mmol/L L-glutamine, penicillin 100 U/mL, and streptomycin 100 g/mL. Once outgrowth of cells was achieved, cells were trypsinized and seeded into 25-cm 2 Petri dishes. Subconfluent cell cultures at the first passage were used after being growth-arrested. Viability of cells was evaluated by dye exclusion test with trypan blue. An aliquot of acetone-fixed cells was used for immunofluorescence studies, and another aliquot of Ϸ250 000 cells was processed for RNA extraction with RNAzol B (Duotech).
Gene Expression Studies
Samples of internal thoracic artery (ITA) (nϭ6) maintained on ice were carefully deprived of both endothelium and adventitia under a microscope. Reverse transcription-polymerase chain reaction (RT-PCR) was performed from total RNA isolated by the guanidinium isothiocyanate method by use of specific primers as reported. 3, 23 Amplification was carried out for 38 cycles at 94°C for 1 minute; 54°C and 60°C, as annealing temperature, for preproET-1 and human ECE-1 (hECE-1), respectively, for 1 minute; and extension at 72°C for 1 minute. To rule out the possibility of amplifying genomic DNA, in some experiments the PCR was carried out with no prior RT of the RNA. Detection of the PCR amplification products was carried out by size-fractionation on 2% agarose gel electrophoresis and ethidium bromide staining.
Statistical Analysis
Results are expressed as meanϮSD or SEM. Comparisons were carried out by 1-way ANOVA followed by Bonferroni's test or with Kruskal-Wallis test for variables not normally distributed. To investigate the relationship between demographic features, mean blood pressure values, number of atherosclerotic sites, and irET-1, a stepwise forward regression analysis (inclusion cutoff value of 0.05) was used. 15 Pearson coefficient was also estimated to assess the relationship of individual variables; a value of PϽ0.05 was considered statistically significant. For analyses, we used the SPSS for Windows statistical package (version. 8.0, SPSS Inc).
Results
Clinical Features of the Subjects
The demographic and clinical features of the subjects studied are summarized in Table 1 . In 16 cases (67%), the indication for surgery was coronary artery disease, and in 4 (17%) it was cancer. Arterial hypertension was present in 58%, diabetes mellitus in 21%, and hypercholesterolemia in 12% of the subjects.
Immunohistochemistry
Staining of the endothelium for irET-1 was seen in all types of arteries, including hypogastric, mesenteric (Figure 1) , ITA, and femoral artery. However, in all arteries from patients with coronary artery or other diseases, irET-1 was detected not only in the endothelium (Figures 2 and 3 , arrows) but also in analysis carried out with irET-1 in the tunica media as dependent variable (Table 2 ) revealed significant direct relationships between irET-1 in the media and mean blood pressure levels, total serum cholesterol, irET-1, and irvWF in the endothelium; an inverse relationship between irET-1 in the media and number of sites involved by atherosclerosis was also found.
Immunofluorescence
As expected, all medial cells of cryosections were recognized by the SM-E7. Almost all intimal cells also reacted to this antibody ( Figure 3D ), indicating that the thin intimal layer was composed primarily of VSMCs. A few cells in the adventitia were stained with this antibody, and in some cases, the anti-ET-1 antibody (not shown) also recognized them. At the immunofluorescence analysis, cultured cells were all positive to both the anti-␣-actin and anti-SM-MHC antibodies, and with both antibodies, the immunofluorescence pattern typical of VSMCs was evident (not shown).
Double immunofluorescence experiments with the monoclonal anti-ET-1 antibody and the anti-hECE-1 antiserum VP-16 showed the colocalization of irET-1 and hECE-1 in VSMCs isolated from human aorta (Figure 4) . No immunofluorescence was seen in the control experiments (not shown). 
Gene Expression
The RT-PCR allowed detection of the preproET-1 and hECE-1 mRNA in all vessel specimens examined ( Figure 5 ). Amplified cDNA fragments of the expected size for both the preproET-1 (314 bp) and hECE-1 (567 bp) and for the control genes were easily detected in samples of the normal arterial wall ( Figure 5 , top) and in preparations in which both endothelium and adventitia were carefully removed ( Figure 5 , top). No amplification was seen in the control PCR containing either no cDNA (water) or total RNA without any prior RT, thereby ruling out the possibility of false-positive results and of amplification of genomic DNA, respectively. Hybridization with capture probes specific for each cDNA investigated confirmed the specificity of the amplification products for each mRNA (not shown). Of interest, similar results for both the preproET-1 and the hECE-1 in VSMCs isolated from ITA were found ( Figure 5 , bottom).
Discussion
Our immunohistochemistry results show that ET-1 is found mainly on endothelium of different types of arteries from young, healthy normotensive individuals (Figure 1 ). However, they also show that irET-1 is detectable in the tunica media, and more precisely on VSMCs, of human arteries obtained ex vivo from patients with coronary artery disease and/or hypertension (Figures 2 and 3 ). This finding is in keeping with earlier reports on atherosclerotic coronary arteries, 24 -26 transplant coronary arteries, 27 atherosclerotic plaques, 28, 29 VSMCs isolated from atherosclerotic coronary arteries, 24 or angioplasty-induced neointima formation. 26 Several lines of evidence support the contention that irET-1 is localized in VSMCs. First, the distribution of the immunostaining within the tunica media of these arteries is consistent with a predominant expression of irET-1 on SM bundles, ie, on VSMCs (Figures 2 and 3) , and it is well established that VSMCs are the only cell type present in the normal tunica media. 30 Second, the irET-1-stained cells were conclusively showing cDNA amplified with preproET-1 and hECE-1 genespecific primers from ITA homogenates (top). Amplifications of cDNA from contiguous sections of same vessels, which were carefully denuded of both endothelium and adventitia, are also shown. Amplification of ET A and ET B receptor genes and of ␤-actin cDNA, as positive controls, and lack of amplification with no DNA template (water) or with no prior RT, as negative controls, is also shown. Amplification of hECE-1 and (although somewhat less intense) also of preproET-1 was evident from endothelium-free ITA. Amplification of both preproET-1 and hECE-1 from human VSMC mRNA is also shown (bottom). Sizes of amplification products were 314 bp for preproET-1, 567 bp for hECE-1, 669 bp for ET A , 760 bp for ET B , and 838 bp for ␤-actin cDNA.
identified as VSMCs by use of SM-E7, an antibody that recognizes only VSMCs, regardless of their differentiative state, 20, 21 and therefore stained all cells of the tunica media ( Figure 3 ). Rare VSMCs expressing ET-1 were also recognized by the anti-myosin antibody in the adventitia close to the external elastic lamina (Figure 3) , but a few adventitial cells expressing irET-1 (not shown) were not, thereby suggesting that adventitial myofibroblasts can also express ET-1. Thus, collectively, our ex vivo findings accord well not only with the in vitro demonstration of a predominant abluminal secretion of ET-1 13, 14 but also with the contention that in patients with coronary artery disease and/or hypertension, the peptide is found in the tunica media, at variance with findings in otherwise healthy young organ donors, in whom the peptide was detectable primarily in the endothelium (Figure 1) . Because both ET A and ET B receptors were found on VSMCs of the media, 31 it might be that the irET-1 detected in this layer is the endothelium-derived peptide bound to its receptors. However, the secretion of ET-1 is constitutive and the half-life of secreted ET-1 in vivo is short (between 1.5 and 7 minutes), because it is quickly inactivated in vascular cells, 32 and the intracellular half-life of ET-1 mRNA is only Ϸ15 minutes. 33 Thus, we propose that ET-1 is synthesized in the tunica media, a hypothesis further suggested by 2 sets of evidence: (1) the demonstration that ET-1 mRNA can be induced in vitro in human VSMCs by growth factors and vasoactive peptides 16,18,24,27-29,34 -36 and (2) the identification of consensus sequences for a number of regulators, including shear stress, the acute-phase reactant regulatory elements, transforming growth factor-␤, insulin, thrombin, epinephrine, interleukin-1, and angiotensin II, in the 5Ј flanking region of the preproET-1 gene 33, 37 and of the hECE-1 gene. 38 Therefore, to investigate this question further, we sought the expression of the preproET-1 and hECE-1 genes in homogenates of the vessel wall of ITA. We found that both genes are expressed not only in homogenates of the wall of these vessels 23 but also, although less intensely, in preparations of ITA that were carefully denuded in vitro of both the endothelium and the adventitia ( Figure 5, top) . Because endothelial cells on capillaries of the media might account for these results, to prove that the preproET-1 and ECE-1 mRNA come from VSMCs, we isolated cells from ITA media and could show that cultured VSMCs coexpress the preproET-1 and hECE-1 mRNA ( Figure 5 , bottom) at an early passage in culture. Thus, although we cannot rule out the possibility that the preproET-1 gene is activated once cells are placed in culture, our present findings, as well as the demonstration that irET-1 is released by cultured human VSMCs, 24 suggest that ET-1 can be made by VSMCs of the tunica media in vivo. This is further supported by the demonstration of a colocalization of both immunoreactive ET-1 and hECE-1 in VSMCs isolated and cultured from the human aorta (Figure 4) .
Our arteries were obtained from a population with a heterogeneous cardiovascular risk profile. Most were from patients in their fifth decade and older who underwent major surgical procedures for coronary artery disease or cancer, and some were from younger organ donors. Thus, to gain insight into the mechanisms linked to ET-1 biosynthesis in the arterial wall layers, we carried out a regression analysis (Table 2) , which unveiled several interesting significant relationships. First, a direct correlation between irvWF and irET-1 in the endothelium was found, and an inverse relationship between irvWF in the endothelium and the number of sites involved by atherosclerosis was seen ( Figure 6 ). This finding indicates that more extensive atherosclerotic involvement is associated with progressive loss of endothelial expression of irvWF. This inverse relationship, although statistically significant (Table 2) , was less evident when irET-1 in the endothelium was taken into consideration, suggesting that the loss of irvWF, ie, of endothelial integrity, is not closely paralleled by a decrease of ET-1 synthesis. We also noticed a significant correlation between irET-1 in the endothelium and in the media (Table 2 ). This observation may suggest that the same factors are involved in regulating the expression of the peptide in both wall layers. However, we found that irET-1 in the media was directly related (PϽ0.05) to the level of mean blood pressure and total serum cholesterol, 2 well-known cardiovascular risk factors, whereas irET-1 in the endothelium was not. We therefore suggest that although endothelial irET-1 is subjected to short-term regulation and/or to loss of endothelial lining integrity, the ET-1 in the media constitutes a more stable pool. A contribution of aging cannot be conclusively ruled out at this stage, but our analysis did not provide support to the contention of a relationship of irET-1 with age either in the endothelium or in the tunica media. The fact that irET-1 in the media was inversely related to the extension of atherosclerosis, ie, to the number of atherosclerotic sites, is intriguing in view of the previous finding of a direct relationship between plasma levels of irET-1 and sites of atherosclerosis. 8 However, it may indicate either a more important role of ET-1 in the initiation rather than in advanced stages of atherosclerosis and/or an increased turnover of ET-1 at the vascular wall level leading to increased plasma levels of the peptide.
Our findings, along with the detection of preproET-1 and ECE-1 mRNA in the tunica media and in isolated VSMCs, suggest that ET-1 synthesis can be activated in vivo in the VSMCs of ITA and other types of arteries from patients with and without coronary artery disease and/or hypertension. Nonetheless, they speak against an exclusive activation of ET-1 biosynthesis in endothelial cells under most pathophysiological conditions, a conclusion that accords well with the results of other 24, 25, 28 but not all investigators. 26 It has recently been shown that blockade of both endothelin receptors with the nonselective agent TAK-044 and inhibition of hECE-1 with an intravenous infusion of phosphoramidon cause peripheral vasodilatation in humans. 39, 40 It was therefore proposed that in vivo generation of ET-1 plays a pivotal role in the maintenance of vascular tone. By showing an ET-1 biosynthesis in the tunica media, our findings provide a rational explanation for these hemodynamic responses.
In conclusion, we found that the preproET-1 and hECE-1 genes are expressed in the tunica media and isolated VSMCs and that irET-1 is detectable not only in the endothelium but also in muscle bundles of the tunica media from histologically normal human arteries obtained ex vivo from patients with different diseases. Thus, these findings are consistent with an important role of ET-1 in the autocrine-paracrine regulation of vascular tone, as recently confirmed by observations in normotensive and hypertensive humans. 39 -43 
